Lemaitre Vascular (LMAT) Operating Expenses (2010 - 2026)

Lemaitre Vascular (LMAT) has 17 years of Operating Expenses data on file, last reported at $30.6 million in Q1 2026.

• On a quarterly basis, Operating Expenses rose 6.35% year-over-year to $30.6 million in Q1 2026; TTM through Mar 2026 was $112.5 million, a 9.55% increase from a year earlier, with the FY2025 full-year figure at $110.6 million, up 12.15% from the prior year.
• Operating Expenses for Q1 2026 stood at $30.6 million, up from $27.4 million in the prior quarter.
• Over the last five years, Operating Expenses for LMAT reached as high as $30.6 million in Q1 2026 and fell as low as $18.0 million in Q1 2022.
• Historically, Operating Expenses has averaged $24.0 million across 5 years, with a median of $24.0 million in 2024.
• Across the five-year window, Operating Expenses soared 40.7% in 2022 and rose 2.76% in 2023, its largest moves.
• Year by year, Operating Expenses stood at $19.1 million in 2022, then grew by 20.81% to $23.1 million in 2023, then gained by 11.61% to $25.7 million in 2024, then grew by 6.3% to $27.4 million in 2025, then gained by 11.93% to $30.6 million in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $30.6 million in Q1 2026, $27.4 million in Q4 2025, and $25.6 million in Q3 2025.